How Long Can We Leave Patients With Pulmonary Arterial Hypertension on Oral Drug Monotreatment?

被引：0
作者：
Ogawa, Aiko [1 ]
Matsubara, Hiromi [1 ]
机构：
[1] Natl Hosp Org, Dept Clin Sci, Okayama Med Ctr, Kita Ku, Okayama 7011192, Japan
来源：
CIRCULATION JOURNAL | 2012年 / 76卷 / 05期
关键词：
SILDENAFIL CITRATE; PROGNOSTIC-FACTORS; SURVIVAL; THERAPY;
D O I：
10.1253/circj.CJ-12-0341
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1089 / 1090
页数：2
相关论文
共 50 条
  • [1] Impact of First-Line Sildenafil Monotreatment for Pulmonary Arterial Hypertension
    Yanagisawa, Ryoji
    Kataoka, Masaharu
    Taguchi, Hiroki
    Kawakami, Takashi
    Tamura, Yuichi
    Fukuda, Keiichi
    Yoshino, Hideaki
    Satoh, Toni
    CIRCULATION JOURNAL, 2012, 76 (05) : 1245 - 1252
  • [2] How a Most Unlikely Drug Changed the Outcome of Pulmonary Arterial Hypertension
    Robbins, Ivan M.
    Hemnes, Anna R.
    PULMONARY CIRCULATION, 2025, 15 (01)
  • [3] Pulmonary hypertension trials: how can we do better?
    Hill, Nicholas S.
    Roberts, Kari
    Preston, Ioana
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (05) : 551 - 558
  • [4] How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?
    Barst, R.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 : 23 - 32
  • [5] The limits of oral therapy in pulmonary arterial hypertension management
    Liu, Qian-Qian
    Jing, Zhi-Cheng
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1731 - 1741
  • [6] Understanding the Pharmacokinetics of Oral Treprostinil in Patients With Pulmonary Arterial Hypertension
    Perez, Vinicio A. de Jesus
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 61 (06) : 471 - 473
  • [7] Medical Therapies for the Treatment of Pulmonary Arterial Hypertension: How Do We Choose?
    MacKenzie, Alison M.
    Peacock, Andrew J.
    CURRENT HYPERTENSION REPORTS, 2015, 17 (07)
  • [8] Long-term treatment of pulmonary arterial hypertension with macitentan in Japanese patients
    Tahara, Nobuhiro
    Dobashi, Hiroaki
    Fukuda, Keiichi
    Funauchi, Masanori
    Hatano, Masaru
    Ikeda, Satoshi
    Joho, Shuji
    Kihara, Yasuki
    Kondo, Takahisa
    Matsushita, Masakazu
    Minamino, Tohru
    Nakanishi, Norifumi
    Okano, Yoshiaki
    Ozaki, Yukio
    Saji, Tsutomu
    Sakai, Satoshi
    Tanabe, Nobuhiro
    Watanabe, Hiroshi
    Yamada, Hidehiro
    Yoshioka, Koichiro
    Hatta, Motonori
    Sasayama, Shigetake
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (06) : 921 - 928
  • [9] The search for an oral prostanoid to treat pulmonary arterial hypertension continues. Are we getting any closer?
    Rich, J.
    Hoeper, M. M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 : 17 - 18
  • [10] Novel approaches to pulmonary arterial hypertension drug discovery
    Sung, Yon K.
    Yuan, Ke
    Perez, Vinicio A. de Jesus
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (04) : 407 - 414
12345